Skip to main content

Table 6 The first 25 query results for query #12

From: The Translational Medicine Ontology and Knowledge Base: driving personalized medicine by bridging the gap between bench and bedside

drug name

disease2 _name

(s)-rolipram

Schizophrenia

(s)-rolipram

Autistic Disorder

(s)-rolipram

Bipolar Disorder

(s)-rolipram

Depression

ACE INHIBITORS, PLAIN

Angioneurotic Edema

ACE INHIBITORS, PLAIN

Hypertension

ACE INHIBITORS, PLAIN

Hypertrophy, Left Ventricular

ACE INHIBITORS, PLAIN

Coronary Disease

ACE INHIBITORS, PLAIN

Alzheimer Disease

ACE INHIBITORS, PLAIN

nondiabetic proteinuric nephropathy

ACE INHIBITORS, PLAIN

Alcoholism

ACE INHIBITORS, PLAIN

Abnormalities

ACE INHIBITORS, PLAIN

Fetal Death

ACE INHIBITORS, PLAIN

Cardiovascular Abnormalities

ACE INHIBITORS, PLAIN

Cardiovascular Diseases

ACE INHIBITORS, PLAIN

Cough

ACE INHIBITORS, PLAIN

Heart Failure

ACE INHIBITORS, PLAIN

Kidney Diseases

ANGIOTENSIN II ANTAGONISTS AND CALCIUM CHANNEL BLOCKERS

Cardiovascular Diseases

ANGIOTENSIN II ANTAGONISTS AND CALCIUM CHANNEL BLOCKERS

Hypertension

ANTIPSYCHOTICS

Schizophrenia

BETA BLOCKING AGENTS

Abnormalities

BETA BLOCKING AGENTS

Fetal Death

BETA BLOCKING AGENTS

Cardiovascular Abnormalities

atenolol

glomerulosclerosis

...

...

  1. A selection of existing marketed drugs in TMKB that might potentially be candidates for AD because they are known to modulate genes that are implicated in the disease.